FDA Recalls COVID-19 Antibody Test Kits for Lacking Regulatory Authorization
Lusys Laboratories is recalling 33,955 COVID-19 antibody test kits distributed across the US and internationally because the product lacks FDA authorization, clearance, or approval for marketing or use.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall for an unauthorized medical device. Although no illnesses or injuries have been reported, unauthorized COVID-19 diagnostic tests represent a serious regulatory violation and pose risk due to unknown accuracy and unverified performance.
Plain-English summary
Lusys Laboratories, Inc. is recalling COVID-19 IgG/IgM Antibody Test kits (Catalog No. I-111), an antibody rapid test intended for detection of COVID-19 IgG and IgM antibodies. Approximately 33,955 kits are affected by this recall.
The recall is being issued because these test kits are not authorized, cleared, or approved by the U.S. Food and Drug Administration for marketing or distribution in the United States. All lots of this product are subject to recall due to lack of required regulatory authorization. The FDA has classified this as a Class I recall.
The affected kits have been distributed in the United States through California, North Carolina, Nevada, Ohio, Tennessee, and Texas, as well as internationally to Canada, China, and Mexico, with additional distribution locations pending confirmation.
The recalled product
- Product
- COVID-19 IgG/IGM Antibody Test For Detection of COVID-19 IgG and IgM antibodies Catalog No: I-111
- Manufacturer
- Lusys Laboratories, Inc.
- Category
- Medical Device — Diagnostic Test
- Affected units
- 33,955
Distribution
Part of a larger recall action
This product is one of 3 recalled by Lusys Laboratories, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Lusys Laboratories, Inc.
See all →- SevereLuscient Diagnostics COVID-19 Antigen Test Kits Recalled for Lack of FDA Authorization
FDA (Devices) · 2022-03-16
- SevereLuSys COVID-19 Antigen Test Kits Recalled for Lack of FDA Authorization
FDA (Devices) · 2022-03-16
- ModerateLusys Recalls Uncleared Ebola Virus One Step Test Kits
FDA (Devices) · 2015-04-15
- SevereLusys Recalls Uncleared Ebola Virus One Step Test Kits
FDA (Devices) · 2015-04-15
- ModerateLusys Recalls Uncleared Ebola Virus One Step Test Kits
FDA (Devices) · 2015-04-15
Same hazard · unauthorized device
See all →- ModerateDVOT SARS-CoV-2 Antigen Test Kit Recalled for Lack of FDA Authorization
FDA (Devices) · 2024-10-09
- HighRoyalVibe Unapproved Medical Devices Recalled Due to Lack of FDA Authorization
FDA (Devices) · 2023-10-18
- SevereCOVID-19 Rapid Test Kits Recalled for Lacking FDA Authorization
FDA (Devices) · 2022-05-11
- SevereFDA Recalls Unauthorized E25Bio COVID-19 Diagnostic Test Kit
FDA (Devices) · 2022-02-16
- SevereLeccurate SARS-CoV-2 Antigen Test Kit Recalled: Not FDA-Approved for U.S. Distribution
FDA (Devices) · 2021-06-09